CJC-1295 no DAC (5mg) & Ipamorelin (5mg) - 10mg Blend Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (amidated C-terminus)

Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (amidated C-terminus)

Unaffected Normal Cells: Studies confirm that PNC-27 has minimal impact on non-cancerous cells

DNA Repair and Genomic Stability: In PARP-overactivated and DNA-damaged cell models as well as irradiated mice

and downstream anabolic/catabolic pathways in various in vitro and animal model systems

CJC-1295 no DAC (5mg) & Ipamorelin (5mg) - 10mg Blend Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ (amidated C-terminus)Overview CJC 1295 no DAC + Ipamorelin Blend combines two research peptides: CJC 1295 without DAC (Modified GRF 1 29), a 29 amino acid GHRH analog, and Ipamorelin, a pentapeptide selective ghrelin mimetic growth hormone secretagogue (GHS). This blend is widely used in laboratory and preclinical research as a model system to investigate synergistic stimulation of pulsatile growth hormone (GH) release, IGF 1 regulation, anabolic signaling, and related